chr15-65003084-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139242.4(MTFMT):āc.1148C>Gā(p.Ala383Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000437 in 1,602,730 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_139242.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTFMT | ENST00000220058.9 | c.1148C>G | p.Ala383Gly | missense_variant | 9/9 | 1 | NM_139242.4 | ENSP00000220058.4 | ||
MTFMT | ENST00000558460.5 | n.1148C>G | non_coding_transcript_exon_variant | 9/10 | 5 | ENSP00000452646.1 | ||||
MTFMT | ENST00000560717.5 | n.*618C>G | non_coding_transcript_exon_variant | 8/8 | 5 | ENSP00000457257.1 | ||||
MTFMT | ENST00000560717.5 | n.*618C>G | 3_prime_UTR_variant | 8/8 | 5 | ENSP00000457257.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151362Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000345 AC: 5AN: 1451368Hom.: 0 Cov.: 31 AF XY: 0.00000277 AC XY: 2AN XY: 721286
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151362Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73832
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2021 | The c.1148C>G (p.A383G) alteration is located in exon 9 (coding exon 9) of the MTFMT gene. This alteration results from a C to G substitution at nucleotide position 1148, causing the alanine (A) at amino acid position 383 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 08, 2022 | This variant has not been reported in the literature in individuals affected with MTFMT-related conditions. ClinVar contains an entry for this variant (Variation ID: 1357429). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 383 of the MTFMT protein (p.Ala383Gly). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at